SARA MORAND: Open Payments
NPI 1649783069 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,569 in 143 payments from 28 companies in 2025. Trend: 2023 $3,625 · 2024 $3,050 · 2025 $3,569
Food & beverage: $3,569
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $741 |
| JAZZ PHARMACEUTICALS INC. | 9 | $419 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $306 |
| Lilly USA, LLC | 7 | $286 |
| Otsuka America Pharmaceutical, Inc. | 10 | $196 |
| Lundbeck LLC | 8 | $184 |
| TG Therapeutics, Inc. | 7 | $168 |
| SK Life Science, Inc. | 6 | $153 |
| ARGENX US, INC. | 2 | $145 |
| CATALYST PHARMACEUTICALS, INC. | 13 | $138 |
Products named: XYWAV, QULIPTA, REXULTI, UBRELVY, KISUNLA, HYQVIA, BRIUMVI, VYVGART.
Industry payments across FL — which companies pay providers there.
